腎除神経デバイス市場：技術、製品、疾患用途、エンドユーザー別-2025-2030年の世界予測

腎除神経デバイス市場は、2023年に2億3,629万米ドルと評価され、2024年には2億6,644万米ドルに達すると予測され、CAGR 13.68%で成長し、2030年には5億7,985万米ドルに達すると予測されています。

腎除神経デバイスは、血圧調節に重要な役割を果たす腎動脈の神経活動を阻害することで、高血圧の治療に用いられる医療機器です。その必要性は、患者が従来の薬物療法に反応しない治療抵抗性高血圧の有病率の増加から生じています。これらの装置の主な用途は、薬理学的手段で緩和を見いだせなかった高血圧患者の血圧を下げることであり、脳卒中、心臓発作、腎不全のリスクを下げる可能性があります。最終用途は一般的にヘルスケア施設内、特にインターベンショナル・カーディオロジー部門です。市場の洞察によると、高血圧症例の増加と老年人口の増加、低侵襲手術技術の技術的進歩が、市場の力強い成長軌道を後押ししています。最新のビジネスチャンスは、機器の有効性と患者のカスタマイズを強化するためのAIと機械学習の統合にあります。医療技術企業とヘルスケア機関のコラボレーションも、進歩の道筋を提供します。しかし、市場の成長には、初期コストの高さ、規制当局の厳しい承認、時折有効性に疑問を呈する臨床試験の結果がまちまちであることなどが課題となっています。この背景には、患者の認識不足と、介入を行う訓練を受けた熟練者の不足があります。事業成長の可能性が高い革新的な分野としては、安全性プロファイルを改善した次世代機器の開拓、高血圧率が急増している新興国市場での使用拡大、遠隔モニタリングと患者エンゲージメントのためのデジタルヘルス技術の活用などが挙げられます。また、高度なデータ分析を通じて患者の属性や行動を理解することも、競争力を高めることにつながります。全体として、腎除神経市場の競争は中程度であり、既存プレーヤーとニッチ企業が市場シェアを獲得するためにイノベーションに注力しています。企業は、臨床結果と市場の信頼性を強化するため、エビデンスに基づく調査に投資することが推奨されます。

市場力学：急速に進化する腎除神経デバイス市場の主要市場インサイトを公開

腎除神経デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 高齢化に伴ううっ血性慢性腎不全の有病率の上昇
  • 低侵襲性外科手術の導入と傾向の高まり
• 市場抑制要因
  • 腎除神経デバイスに関連する高コスト
• 市場機会
  • 腎除神経デバイスの技術的進歩と改良
  • 腎除神経の臨床ガイドラインの継続的な発行と臨床評価研究の増加
• 市場の課題
  • 製品承認のための厳しい政府規制と経験豊富なヘルスケア専門家の不足

ポーターの5つの力：腎除神経デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：腎除神経デバイス市場における外部からの影響の把握

外部マクロ環境要因は、腎除神経デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析腎除神経デバイス市場における競合情勢の把握

腎除神経デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス腎除神経デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、腎除神経デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化に伴い慢性腎不全の罹患率が上昇
    • 低侵襲手術の採用と傾向の高まり
  • 抑制要因
    • 腎除神経デバイスに関連する高コスト
  • 機会
    • 腎除神経デバイスにおける技術の進歩と改善
    • 腎神経除去に関する臨床ガイドラインの継続的な出版と臨床評価研究の増加
  • 課題
    • 製品承認に関する厳しい政府規制と経験豊富なヘルスケア専門家の不足
• 市場セグメンテーション分析
  • 技術：超音波による腎神経除去技術の採用率が高い
  • 製品：処置時間の短縮のため、多電極カテーテルを積極的に使用
  • 疾患応用：高血圧治療における腎除神経デバイスの使用増加
  • エンドユーザー：外来診療センターは、低侵襲で費用対効果の高いソリューションとして腎除神経デバイスを優先します
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 腎除神経デバイス市場：技術別

• マイクロインフュージョンベース
• 薬理学的アブレーション
• 無線周波数ベース
• 超音波ベース

第7章 腎除神経デバイス市場：製品別

• カテーテル
  • マルチ電極カテーテル
  • 単電極カテーテル
• 神経修飾剤
• RFジェネレータ

第8章 腎除神経デバイス市場疾患別用途

• 糖尿病
• 心不全
• 高血圧
• 腎不全

第9章 腎除神経デバイス市場：エンドユーザー別

• 外来診療センター
• 診断センターと病院
• 調査と学術

第10章 南北アメリカの腎除神経デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の腎除神経デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの腎除神経デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • レコーメディカルと大塚メディカルデバイス、高血圧治療の初のFDA承認腎神経除去システムを発表
  • FDAがVerve MedicalのIDE腎盂神経除去試験を承認
  • 韓国のスタートアップ企業カロス、高血圧治療のための腎神経除去装置の開発で350万米ドルの助成金を獲得
  • 治療抵抗性高血圧症における超音波アブレーションを用いた腎神経除去術の早期効果評価がドイツで実施中
  • Andera Partnersが高血圧治療のための有望なデバイスを開発する医療技術企業SoniVieに投資
  • フランスのメドトロニック社製腎除神経カテーテルSYMPLICITY SPYRALの移行カバー
  • 上海ゴールデンリーフメディカルテック株式会社がシリーズCラウンドで数百万人民元を確保
  • SPYRAL HTN-ON MED試験は、他のSPYRAL HTN腎神経除去試験と一致する有意義な臨床的利点を実証しました
  • ソニヴィー、腎動脈除神経TIVUS技術を用いた高血圧治療のパイロットスタディでFDAからIDE承認を取得
  • Ablative Solutions、シリーズD資金調達ラウンドで9,140万米ドルを調達
  • Clinical AcceleratorがVerve Medicalと提携し、治療抵抗性高血圧症の早期ヒト実現可能性研究を実施することを発表

企業一覧

• Abbott Laboratories
• Ablative Solutions, Inc.
• AngioDynamics, Inc.
• Aria CV, Inc.
• AtriCure, Inc.
• Bio-Heart
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Kalos Medical
• Medtronic PLC
• Mercator MedSystems, Inc.
• Otsuka Holdings Co., Ltd.
• Shanghai Meiliweiye Medical Technology Co., Ltd.
• SoniVie
• Symap Medical, Ltd.
• Symple Surgical, Inc.
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. RENAL DENERVATION DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. RENAL DENERVATION DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
• FIGURE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 6. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 14. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 16. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 18. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 22. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RENAL DENERVATION DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
• TABLE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 6. RENAL DENERVATION DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 15. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 16. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 17. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 18. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 19. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 20. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 21. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 22. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 23. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 24. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 25. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 26. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 27. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 28. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 29. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 30. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 31. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 32. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 33. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 34. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 35. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 36. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 37. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 38. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 39. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 40. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 41. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 42. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 43. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 44. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 45. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 46. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 47. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 48. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 49. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 50. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 51. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 52. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 53. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 54. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 55. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 56. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 57. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 58. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 59. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
• TABLE 60. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 61. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 62. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 63. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 64. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 65. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 66. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 67. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 68. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 69. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 70. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 71. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 72. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 73. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 74. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 75. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 76. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 77. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 78. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 79. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 80. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 81. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 82. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 83. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 84. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 85. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 86. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 87. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 88. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 89. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 90. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 91. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 92. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 93. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 94. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 95. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 96. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 97. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 98. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 99. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 100. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 101. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 102. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 103. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 104. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 105. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 106. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 107. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 108. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 109. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 110. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 111. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 112. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 113. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 114. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 115. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 116. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 117. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 118. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 119. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 120. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 121. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 122. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 123. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 124. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 125. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 132. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 133. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 134. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 135. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 136. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 137. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 138. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 139. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 140. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 141. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 142. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 143. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 144. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 145. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 146. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 147. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 148. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 149. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 150. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 151. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 152. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 153. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 154. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 155. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 156. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 157. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 158. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 159. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 160. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 161. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 162. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 163. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 164. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 165. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 166. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 167. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 168. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 169. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 170. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 171. NETHERLANDS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 172. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 173. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 174. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 175. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 176. NIGERIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 177. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 178. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 179. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 180. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 181. NORWAY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 182. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 183. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 184. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 185. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 186. POLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 187. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 188. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 189. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 190. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 191. QATAR RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 192. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 193. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 194. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 195. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 196. RUSSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 197. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 198. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 199. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 200. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 201. SAUDI ARABIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 202. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 203. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 204. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 205. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 206. SOUTH AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 207. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 208. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 209. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 210. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 211. SPAIN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 212. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 213. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 214. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 215. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 216. SWEDEN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 217. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 218. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 219. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 220. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 221. SWITZERLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 222. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 223. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 224. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 225. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 226. TURKEY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 227. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 228. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 229. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 230. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 231. UNITED ARAB EMIRATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 232. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD THOUSAND)
• TABLE 233. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2030 (USD THOUSAND)
• TABLE 234. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD THOUSAND)
• TABLE 235. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2030 (USD THOUSAND)
• TABLE 236. UNITED KINGDOM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 237. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 238. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Renal Denervation Devices Market was valued at USD 236.29 million in 2023, expected to reach USD 266.44 million in 2024, and is projected to grow at a CAGR of 13.68%, to USD 579.85 million by 2030.

Renal denervation devices are medical tools used to treat hypertension by disrupting nerve activity in the renal arteries, which play a crucial role in blood pressure regulation. Their necessity arises from the increasing prevalence of treatment-resistant hypertension, a condition where patients fail to respond to traditional medications. The primary application of these devices is in reducing blood pressure among hypertensive patients who have not found relief through pharmacological means, potentially lowering the risks of stroke, heart attack, and kidney failure. End-use is typically within healthcare facilities, specifically interventional cardiology departments. Market insights reveal a robust growth trajectory fueled by rising hypertension cases and a growing geriatric population, coupled with technological advancements in minimally invasive surgical techniques. The latest opportunities lie in the integration of AI and machine learning to enhance device efficacy and patient customization. Collaborations between medical technology companies and healthcare institutions also offer pathways for advancements. However, market growth is challenged by high initial costs, stringent regulatory approvals, and the mixed results from clinical trials that occasionally question efficacy. In this context, limitations involve a lack of awareness among patients and a deficiency in skilled personnel trained to perform the interventions. Innovative areas with high potential for business growth include the development of next-generation devices with improved safety profiles, expanding use in emerging markets where hypertension rates are skyrocketing, and leveraging digital health technologies for remote monitoring and patient engagement. Understanding patient demographics and behavior through advanced data analytics can also provide a competitive edge. Overall, the renal denervation market is moderately competitive, with a blend of established players and niche companies focusing on innovation to claim market share. Companies are advised to invest in evidence-based research to strengthen clinical outcomes and market credibility.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Renal Denervation Devices Market

The Renal Denervation Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of congestive chronic renal failure with aging population
  • Growing adoption and inclination towards minimally invasive surgical procedures
• Market Restraints
  • High cost associated with renal denervation devices
• Market Opportunities
  • Technological advancements and improvements in renal denervation devices
  • Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
• Market Challenges
  • Strict government regulations for product approval coupled with lack of experienced healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Renal Denervation Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Renal Denervation Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Renal Denervation Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Renal Denervation Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Renal Denervation Devices Market

A detailed market share analysis in the Renal Denervation Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Renal Denervation Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Renal Denervation Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., AngioDynamics, Inc., Aria CV, Inc., AtriCure, Inc., Bio-Heart, Boston Scientific Corporation, Cardinal Health, Inc., Kalos Medical, Medtronic PLC, Mercator MedSystems, Inc., Otsuka Holdings Co., Ltd., Shanghai Meiliweiye Medical Technology Co., Ltd., SoniVie, Symap Medical, Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based, and Ultrasound-Based.
• Based on Products, market is studied across Catheters, Nerve Modifying Agents, and RF Generator. The Catheters is further studied across Multi Electrode Catheter and Single Electrode Catheter.
• Based on Disease Application, market is studied across Diabetes, Heart Failure, Hypertension, and Renal Failure.
• Based on End-User, market is studied across Ambulatory Care Centers, Diagnostic Centers & Hospitals, and Research & Academia.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of congestive chronic renal failure with aging population
    • 5.1.1.2. Growing adoption and inclination towards minimally invasive surgical procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with renal denervation devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and improvements in renal denervation devices
    • 5.1.3.2. Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
  • 5.1.4. Challenges
    • 5.1.4.1. Strict government regulations for product approval coupled with lack of experienced healthcare professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: High adoption of ultrasound-based renal denervation technology
  • 5.2.2. Product: Significant use of multi-electrode catheters for their shorter-time of procedures
  • 5.2.3. Disease Application: Proliferating use of renal denervation devices for treating hypertension
  • 5.2.4. End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Renal Denervation Devices Market, by Technology

• 6.1. Introduction
• 6.2. Micro-Infusion-Based
• 6.3. Pharmacologic Ablation
• 6.4. Radiofrequency-Based
• 6.5. Ultrasound-Based

7. Renal Denervation Devices Market, by Products

• 7.1. Introduction
• 7.2. Catheters
  • 7.2.1. Multi Electrode Catheter
  • 7.2.2. Single Electrode Catheter
• 7.3. Nerve Modifying Agents
• 7.4. RF Generator

8. Renal Denervation Devices Market, by Disease Application

• 8.1. Introduction
• 8.2. Diabetes
• 8.3. Heart Failure
• 8.4. Hypertension
• 8.5. Renal Failure

9. Renal Denervation Devices Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Care Centers
• 9.3. Diagnostic Centers & Hospitals
• 9.4. Research & Academia

10. Americas Renal Denervation Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Renal Denervation Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Renal Denervation Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
  • 13.3.2. FDA Approves Verve Medical's IDE Renal Pelvic Denervation Trial
  • 13.3.3. Korean Startup Kalos Gets USD 3.5 Million Grant to Develop Renal Denervation Device for hypertension Treatment
  • 13.3.4. Renal Denervation Using Ultrasound Ablation in Treatment-Resistant Hypertension is Being Evaluated for Early Benefit Assessment in Germany
  • 13.3.5. Andera Partners Invests in SoniVie, a Medtech Company Developing a Promising Device for the Treatment of Hypertension
  • 13.3.6. Transitional Coverage for Renal Denervation Catheter SYMPLICITY SPYRAL from Medtronic in France
  • 13.3.7. Shanghai Golden Leaf Med Tec Co., Ltd Secures Hundreds of Mns of CNY in Series C Round
  • 13.3.8. SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with other SPYRAL HTN Renal Denervation Trials
  • 13.3.9. SoniVie Receives IDE Approval from FDA for its Pilot Study to Treat Hypertension with its Renal Artery Denervation TIVUS Technology
  • 13.3.10. Ablative Solutions Raises USD 91.4 Million in Series D Financing Round
  • 13.3.11. Clinical Accelerator Announces Collaboration with Verve Medical to Conduct an Early Human Feasibility Study for Treatment-Resistant Hypertension

Companies Mentioned

• 1. Abbott Laboratories
• 2. Ablative Solutions, Inc.
• 3. AngioDynamics, Inc.
• 4. Aria CV, Inc.
• 5. AtriCure, Inc.
• 6. Bio-Heart
• 7. Boston Scientific Corporation
• 8. Cardinal Health, Inc.
• 9. Kalos Medical
• 10. Medtronic PLC
• 11. Mercator MedSystems, Inc.
• 12. Otsuka Holdings Co., Ltd.
• 13. Shanghai Meiliweiye Medical Technology Co., Ltd.
• 14. SoniVie
• 15. Symap Medical, Ltd.
• 16. Symple Surgical, Inc.
• 17. Terumo Corporation